Avid Bioservices Inc (CDMO)

[Couch]

The institutions represented by NCCN are some of the most prestigious and advanced global bodies that partner on development of medicines, run trials and treat patients.

I'm very confused reading some posts that look at this as an act of desperation or hedging of bets. Getting a product to be accepted into NCCN for evaluation and broad testing is a privilege - not an entitlement.

So - yes. This provides both an insurance policy for high integrity and access to the basket of modern meds that various pharmas and research institutions have deployed or are in the process of evaluating. It's the best federated model one can get where the best expertise in drug development and testing comes together with the broadest range of combo candidates to see what can be brought to bear.

It's all pointing to the strategy of filing for Lung with Bavi/Doce closely followed by multiple filing for multiple indications through the various collaborations - should they produce the results we hope.

Thanks MH. I had no doubt that this collaboration with NCCN wasn't born out of desperation but actually nice to hear it from one with an inside perspective. To me this collaboration highlights additional proof that PPHM believes it has what it says it has - astronomical value in Bavi. It comes down to your last statement - "should they produce the results we hope."

In other words, should Bavi prove effective in helping other drugs fight cancer this collaboration with NCCN is only going to help Peregrine do so more effectively and quickly. Seems to me time and money well spent.

My best,
Couch